Pivotal bioVenture Partners Investment Advisor LLC
Venture CapitalTop Portfolio Positions
12 positions ·
$279,605,926 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| PCVX |
Vaxcyte, Inc.
Healthcare
|
1,372,425 | $79,751,616 | 28.52% | |
| OCS |
Oculis Holding AG
Healthcare
|
1,680,283 | $44,678,724 | 15.98% | |
| EVMN |
Evommune, Inc.
Healthcare
|
1,926,943 | $44,300,419 | 15.84% | |
| ARQT |
Arcutis Biotherapeutics, Inc.
Healthcare
|
1,355,892 | $31,944,815 | 11.42% | |
| TRVI |
Trevi Therapeutics, Inc.
Healthcare
|
1,553,726 | $18,535,951 | 6.63% | |
| IMNM |
Immunome Inc.
Healthcare
|
732,512 | $16,020,037 | 5.73% | |
| MPLT |
MapLight Therapeutics, Inc.
Healthcare
|
611,447 | $12,430,717 | 4.45% | |
| ZBIO |
Zenas BioPharma, Inc.
Healthcare
|
591,991 | $11,573,424 | 4.14% | |
| BIOA |
BioAge Labs, Inc.
Healthcare
|
653,374 | $11,427,511 | 4.09% | |
| AVTX |
Avalo Therapeutics, Inc.
Healthcare
|
295,933 | $4,418,279 | 1.58% |
Portfolio Trend
22 quarters · across all stocks
Holdings in PCVX
Shares Held
Position Value (USD)
22 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $79,751,616 | 1,372,425 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $63,323,689 | 1,372,425 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $49,434,748 | 1,372,425 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $42,429,613 | 1,305,125 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $26,837,315 | 710,734 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $57,615,851 | 703,834 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $73,080,121 | 639,539 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $59,882,148 | 793,036 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $54,172,289 | 793,036 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $49,802,660 | 793,036 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $40,428,975 | 793,036 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $39,604,217 | 793,036 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $25,975,101 | 693,039 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $33,231,220 | 693,039 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $18,624,936 | 776,039 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $18,107,932 | 832,166 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $26,842,362 | 1,111,485 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $26,442,228 | 1,111,485 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $35,655,530 | 1,405,421 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $31,636,026 | 1,405,421 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $27,757,064 | 1,405,421 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $59,064,312 | 2,222,970 | Shares | Defined | 2021-02-09 | |
| No 13F history on record for this holder in this stock. | ||||||